颈动脉内膜剥脱术与支架术的无症状状态持续时间及结局:CREST 试验分析
在 CREST 试验的 1181 例无症状患者中,1104 例(93%)为一直无症状(AA),77 例(7%)为既往有症状但当前无症状(PS)。围术期卒中/死亡、4 年卒中/死亡及 4 年主要终点在 AA 与 PS 组间均无差异,CEA 和 CAS 分别分析亦无差异。
要点
- 无症状患者中仅少数(7%)有同侧既往症状,当前无症状但既往有症状者与一直无症状者结局无差异。
- 围术期卒中/死亡、4 年卒中/死亡及 4 年主要终点在 AA 与 PS 组间均无统计学差异。
- CEA 和 CAS 分别分析时,AA 与 PS 组间上述结局同样无差异。
核心结论
- 在 CREST 试验中,无症状患者仅少数有同侧既往症状,AA 与 PS 患者的围术期及 4 年结局无差异。
研究设计与样本
- CREST 随机试验中无症状患者的回顾性比较分析,共 1181 例,AA 1104 例(93%),PS 77 例(7%)。
- 患者随机接受颈动脉内膜剥脱术(CEA)或颈动脉支架置入/血管成形术(CAS),采用校正年龄、性别和治疗的风险比例模型分析。
主要发现
- pooled CAS+CEA 人群中,AA 与 PS 的围术期卒中/死亡分别为 2.0% vs 1.3%,4 年卒中/死亡 3.6% vs 3.2%,主要终点 5.2% vs 5.8%,均无差异。
- CEA 组中,AA 与 PS 的围术期卒中/死亡 1.5% vs 0%,4 年卒中/死亡 2.7% vs 0%,主要终点 5.1% vs 2.4%。
- CAS 组中,AA 与 PS 的围术期卒中/死亡 2.5% vs 2.8%,4 年卒中/死亡 4.4% vs 6.9%,主要终点 5.3% vs 9.8%。
临床怎么用
- 对于当前无症状但既往有同侧症状的患者,血运重建(CEA 或 CAS)的围术期及 4 年风险与一直无症状者相似,可参考相同决策框架。
局限性
- PS 组样本量小(77 例),可能不足以检测组间微小差异。
- 分析为 CREST 试验的事后比较,非预设主要分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most carotid revascularization studies define asymptomatic as symptom-free for more than 180 days; however, it is unknown if intervention carries similar risk among those currently asymptomatic but with previous symptoms (PS) vs those who were always asymptomatic (AA). METHODS: We compared the periprocedural and 4-year risks of PS vs AA patients in the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST) randomized to carotid endarterectomy (CEA) or carotid artery stenting (CAS)/angioplasty. Proportional hazards models adjusting for age, sex, and treatment were used to assess the risk of periprocedural stroke and/or death (S+D; any S+D during periprocedural period), stroke and death at 4 years (any S+D within the periprocedural period and ipsilateral stroke out to 4 years) and the primary end point at 4 years (any stroke, death, and myocardial infarction within the periprocedural period and ipsilateral stroke out to 4 years). Analysis was performed pooling the CEA-treated and CAS-treated patients, and separately for each treatment. RESULTS: Of 1181 asymptomatic patients randomized in CREST, 1104 (93%) were AA and 77 (7%) were PS. There was no difference in risk when comparing the AA and PS cohorts in the pooled CAS+CEA population for periprocedural S+D (2.0% vs 1.3%), S+D at 4 years (3.6% vs 3.2%), or the primary end point (5.2% vs 5.8%). There were also no differences among those assigned to CEA (periprocedural S+D, 1.5% vs 0%; S+D at 4 years, 2.7% vs 0%; or primary end point, 5.1% vs 2.4%) or CAS (periprocedural S+D, 2.5% vs 2.8%; S+D at 4 years, 4.4% vs 6.9%; or primary end point, 5.3% vs 9.8%) when analyzed separately. CONCLUSIONS: In CREST, only a small minority of asymptomatic patients had previous ipsilateral symptoms. The outcomes of periprocedural S+D, periprocedural S+D, and ipsilateral stroke up to 4 years, and the primary end point did not differ for AA patients compared with PS patients.
引用
- Moore WS, Voeks JH, Roubin GS, et al. Duration of asymptomatic status and outcomes following carotid endarterectomy and carotid artery stenting in the Carotid Revascularization Endarterectomy vs Stenting Trial. J Vasc Surg. 2019. PMID: 30630649. doi:10.1016/j.jvs.2018.09.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。